A Scoping Review on the Use of Antibiotic-Impregnated Beads and Applications to Vascular Surgery

Introduction: Surgical site infection (SSI) presents a ubiquitous concern to surgical specialties, especially in the presence of prosthetic material. Antibiotic-impregnated beads present a novel and evolving means to combat this condition. This review aims to analyze the quality of evidence and methods of antibiotic bead use, particularly for application within vascular surgery. Methods: A systematic scoping review was conducted within Embase, MEDLINE, and the Cochrane Registry of Randomized Controlled Trials. Articles were evaluated by 2 independent reviewers. Level of evidence was evaluated using the Oxford Center for Evidence-Based Medicine Criteria and the Cochrane Risk of Bias Tool for Randomized Controlled Trials. Results: The search yielded 6951 papers, with 275 included for final analysis. Publications increased in frequency from 1978 to the present. The most common formulation was polymethyl methacrylate; however publications on biodegradable formulations, including calcium sulfate beads, have been published with increasing frequency. Most publications had positive conclusions (94.2%); however, the data was mainly subjective and may be prone to publication bias. Only 11 randomized controlled trials were identified and all but one was evaluated to be at a high risk of bias. The most common indication was for osteomyelitis (52%), orthopedic prosthetic infections (20%), and trauma (9%). Within vascular surgery, beads have been used primarily for the treatment of graft infection, with freedom from recurrence rates being reported from 41% to 87.5%. Conclusions: Antibiotic-impregnated beads provide a means to deliver high doses of antibiotic directly to a surgical site, without the risks of parenteral therapy. There has yet to be significant high-level quality data published on their use. There is a large body of evidence that suggests antibiotic beads may be used in SSIs in high-risk patients, prosthetic infections, and other complex surgical infections. Important potential areas of application in vascular surgery include graft infection, prevention of wound infection in high-risk patients, and diabetic foot infection.

Download Full-text

Re: Preoperative intra-aortic counterpulsation in high-risk patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials

European Journal of Cardio-Thoracic Surgery ◽

10.1093/ejcts/ezw141 ◽

2016 ◽

Vol 51 (1) ◽

pp. 193.2-194 ◽

Cited By ~ 1

Author(s):

Stephen Su Yang

Keyword(s):

Cardiac Surgery ◽

High Risk ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

High Risk Patients ◽

Randomized Controlled ◽

Risk Patients

Download Full-text

CLOPIDOGREL AND ASPIRIN VERSUS ASPIRIN ALONE IN HIGH-RISK PATIENTS WITH ESTABLISHED VASCULAR DISEASE; A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(10)61045-5 ◽

2010 ◽

Vol 55 (10) ◽

pp. A112.E1044

Author(s):

Swapna Kamireddy ◽

Marc S. Sabatine ◽

Deepak L. Bhatt ◽

Steven R. Steinhubl ◽

William E. Boden

Keyword(s):

High Risk ◽

Randomized Controlled Trials ◽

Vascular Disease ◽

Meta Analysis ◽

Controlled Trials ◽

High Risk Patients ◽

Randomized Controlled ◽

Risk Patients

Download Full-text

Preoperative intra-aortic counterpulsation in high-risk patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials

European Journal of Cardio-Thoracic Surgery ◽

10.1093/ejcts/ezv258 ◽

2015 ◽

Vol 49 (1) ◽

pp. 5-17 ◽

Cited By ~ 37

Author(s):

Kevin Pilarczyk ◽

Andreas Boening ◽

Heinz Jakob ◽

Georg Langebartels ◽

Andreas Markewitz ◽

...

Keyword(s):

Cardiac Surgery ◽

High Risk ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

High Risk Patients ◽

Randomized Controlled ◽

Risk Patients

Download Full-text

Is reiki or prayer effective in relieving pain during hospitalization for cesarean? A systematic review and meta-analysis of randomized controlled trials

Sao Paulo Medical Journal ◽

10.1590/1516-3180.2016.0267031116 ◽

2017 ◽

Vol 135 (2) ◽

pp. 123-132 ◽

Cited By ~ 3

Author(s):

Guilherme Augusto Rago Ferraz ◽

Meline Rosseto Kron Rodrigues ◽

Silvana Andrea Molina Lima ◽

Marcelo Aparecido Ferraz Lima ◽

Gabriela Lopes Maia ◽

...

Keyword(s):

Systematic Review ◽

High Risk ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Spiritual Healing ◽

Risk Of Bias ◽

Controlled Trials ◽

Randomized Controlled ◽

Significant Difference ◽

Section Design

ABSTRACT CONTEXT AND OBJECTIVE: This systematic review compared reiki and prayer with drug use for relieving pain during hospitalization for cesarean, given that the popularity of integrative medicine and spiritual healing has been increasing. It had the aim of evaluating whether reiki or prayer is effective in relieving pain during cesarean section. DESIGN AND SETTING: Systematic review with meta-analysis conducted at Botucatu Medical School, UNESP, São Paulo, Brazil. METHODS: The following databases were searched up to March 2016: MEDLINE, Embase, LILACS and CENTRAL. Randomized controlled trials published in English or Portuguese were included in the review. Two reviewers independently screened eligible articles, extracted data and assessed the risk of bias. A GRADE table was produced to evaluate the risk of bias. RESULTS: There was evidence with a high risk of bias showing a statistically significant decrease in pain score through use of reiki and prayer, in relation to the protocol group: mean difference = -1.68; 95% confidence interval: -1.92 to -1.43; P < 0.00001; I2 = 92%. Furthermore, there was no statistically significant difference in heart rate or systolic or diastolic blood pressure. CONCLUSION: Evidence with a high risk of bias suggested that reiki and prayer meditation might be associated with pain reduction.

Download Full-text

The treatment of premenstrual syndrome with preparations of Vitex Agnus Castus (Chaste-berry): A systematic review and meta-analysis

European Psychiatry ◽

10.1016/j.eurpsy.2017.01.1863 ◽

2017 ◽

Vol 41 (S1) ◽

pp. s907-s908

Author(s):

P. Schulte ◽

A. Verkaik ◽

A. Kamperman ◽

R. Van Westrhenen

Keyword(s):

High Risk ◽

Randomized Controlled Trials ◽

Premenstrual Syndrome ◽

Meta Analysis ◽

Risk Of Bias ◽

Reproductive Age ◽

Controlled Trials ◽

Extensive Literature ◽

Randomized Controlled ◽

Agnus Castus

IntroductionFive to 8% of women of reproductive age suffer from moderate to severe symptoms of premenstrual syndrome associated with substantial distress or functional impairment.ObjectiveTo determine the efficacy, tolerability and acceptability of Vitex agnus castus (VAC, chaste-berry) preparations for treatment of premenstrual syndrome (PMS).MethodsAfter an extensive literature search all randomized controlled trials of VAC in women with PMS and/or premenstrual dysphoric disorder were included.ResultsWe found 17 randomized controlled trials of VAC in the treatment of PMS of which 14 studies could be included in the quantitative analysis. All trials, except one, found the Vitex agnus castus preparation to be more efficacious than placebo, pyridoxine and magnesium for either total symptom score or individual symptoms or symptom clusters. Unfortunately, the majority of trials is hampered by a high risk of bias. The pooled effect of VAC in placebo-controlled trials was large (Hedge's g: −1.21; 95% CI: −1.53 to −0.88), but heterogeneity extremely high (I2 = 91%). We could not single out distinct factors that could explain this heterogeneity. The funnel plot and Egger's tests suggest the presence of bias over the full set of studies and effect sizes.ConclusionAlthough meta-analysis shows a large pooled effect of VAC in placebo-controlled trials the high risk of bias, high heterogeneity and risk of publication bias of the included studies preclude a definitive conclusion. The pooled treatment effects should be viewed as merely explorative and, at best, overestimating the real treatment effect of VAC for PMS symptomatology.Disclosure of interestP.S. reports personal fees from H. Lundbeck A/S, outside the submitted work. The other authors have not supplied their declaration of competing interest.

Download Full-text

Effectiveness of integrated nursing interventions for fatigue in patients with advanced cancer: a systematic review of randomized controlled trials

Frontiers of Nursing ◽

10.2478/fon-2019-0027 ◽

2019 ◽

Vol 6 (3) ◽

pp. 203-210

Author(s):

Xiao-Lin Zuo ◽

Yan Wen ◽

Shang-Qun Gong ◽

Fan-Jie Meng

Keyword(s):

Systematic Review ◽

High Risk ◽

Randomized Controlled Trials ◽

Advanced Cancer ◽

Intervention Group ◽

Risk Of Bias ◽

Cochrane Library ◽

Controlled Trials ◽

Nursing Interventions ◽

Randomized Controlled

Abstract Objective To evaluate the effectiveness of integrated nursing interventions for fatigue in patients with advanced cancer. Methods Medline, Pubmed, Embase, CINAHL, Web of Science, and the Cochrane Library were searched systematically till June 2017. A systematic review was conducted to collect randomized controlled trials (RCTs) reporting on the effect of nurse-driven interventions to improve fatigue in patients with advanced cancer. Quality assessment was conducted using the Cochrane Collaboration’s risk of bias tool. Results Six RCTs involving 736 adult participants were included. The fatigue intensity was improved significantly by nursing interventions. The analyzed results revealed significant improvements in the intervention group: less than 3 months (standard mean difference [SMD] = −0.33, 95% confidence interval [CI] [−0.48, −0.19], P < 0.01) and more than or equal to 3 months (SMD = −0.40, 95% CI [−0.57, −0.24], P < 0.01). Four studies with a moderate risk of bias were judged, and the remaining studies were at high risk of bias. Conclusions The results indicate that integrated nursing interventions may relieve fatigue in patients with advanced cancer. However, due to the high risk of bias in most of the included studies and the diversity of interventions, the results and implementation process should be carefully monitored.

Download Full-text

Evaluation of Risks of Bias in Addiction Medicine Randomized Controlled Trials

Alcohol and Alcoholism ◽

10.1093/alcalc/agaa074 ◽

2020 ◽

Author(s):

Cole Wayant ◽

Daniel Tritz ◽

Jarryd Horn ◽

Matt Crow ◽

Matt Vassar

Keyword(s):

Sensitivity Analysis ◽

High Risk ◽

Randomized Controlled Trials ◽

Risk Of Bias ◽

Controlled Trials ◽

Publicly Funded ◽

Addiction Medicine ◽

Randomized Controlled ◽

Trial Outcomes ◽

Risk Judgments

Abstract Aims Perhaps the most important step when designing and conducting randomized controlled trials (RCTs) in addiction is to put methodological safeguards in place to minimize the likelihood for bias to affect trial outcomes. In this study, we applied the revised Cochrane risk of bias tool (ROB 2) to RCTs of drug, alcohol or tobacco interventions. Methods We searched for trials published in 15 addiction medicine journals over a 7-year period. Our primary endpoint is the risk of bias of included studies. We conducted a sensitivity analysis of publicly funded trials. Results Overall, included RCTs were most often at high risk of bias per our judgments (244/487, 50.1%). However, significant proportions of included RCTs were at low risk of bias (123/487, 25.3%) or some concerns for bias (120/497, 24.6%). RCTs with behavioral modification interventions (19/44, 43.2%) and alcohol interventions (80/150, 53.3%) had the highest proportion of high-risk judgments. In a sensitivity analysis of publicly funded RCTs), 195/386 (50.5%) were at high risk of bias. Conclusions Approximately half of included drug, alcohol or tobacco RCTs in our sample were judged to be at high risk of bias with the most common reason being a lack of proper blinding or proper description of blinding. Key action items to reduce bias in future addiction RCTs include adequate randomization, blinding and inclusion of a trial registry number and protocol.

Download Full-text

Assessment of Risk of Bias in Osteosarcoma and Ewing’s Sarcoma Randomized Controlled Trials: A Systematic Review

Current Oncology ◽

10.3390/curroncol28050322 ◽

2021 ◽

Vol 28 (5) ◽

pp. 3771-3794

Author(s):

Robert Koucheki ◽

Aaron M. Gazendam ◽

Jonathan R. Perera ◽

Anthony Griffin ◽

Peter Ferguson ◽

...

Keyword(s):

High Risk ◽

Randomized Controlled Trials ◽

Ewing’S Sarcoma ◽

Ewing's Sarcoma ◽

Conflicts Of Interest ◽

Risk Of Bias ◽

Controlled Trials ◽

Industry Funding ◽

Randomized Controlled ◽

Unclear Risk

Aim: The aim of this study was to systematically assess the risk of bias in osteosarcoma and Ewing’s sarcoma (ES) randomized controlled trials (RCT) and to examine the relationships between bias and conflict of interest/industry sponsorship. Methods: An OVID-MEDLINE search was performed (1976–2019). Using the Cochrane Collaboration guidelines, two reviewers independently assessed the prevalence of risk of bias in different RCT design domains. The relationship between conflicts of interest and industry funding with the frequency of bias was examined. Results: 73 RCTs met inclusion criteria. Prevalence of low-risk bias domains was 47.3%, unclear-risk domains 47.8%, and 4.9% of the domains had a high-risk of bias. Domains with the highest risk of bias were blinding of participants/personnel and outcome assessors, followed by randomization and allocation concealment. Overtime, frequency of unclear-risk of bias domains decreased (χ2 = 5.32, p = 0.02), whilst low and high-risk domains increased (χ2 = 8.13, p = 0.004). Studies with conflicts of interest and industry sponsorships were 4.2 and 3.1 times more likely to have design domains with a high-risk of bias (p < 0.05). Conclusion: This study demonstrates that sources of potential bias are prevalent in both osteosarcoma and ES RCTs. Studies with financial conflicts of interest and industry sponsors were significantly more likely to have domains with a high-risk of bias. Improvements in reporting and adherence to proper methodology will reduce the risk of bias and improve the validity of the results of RCTs in osteosarcoma and ES.

Download Full-text